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Bioconversion:  Chemical conversion of a 
substance using biological methods (enzymes or 
whole cells, biocatalysis or biotransformation).
Biotransformation: Chemical conversion of a 
substance into a desired product with the aid of a 
living whole cell, containing the necessary 
enzyme(s).
Biocatalysis: Chemical conversion of a substance 
into a desired product with the aid of a free or 
immobilized enzyme.
.
Biosynthesis:  De novo production of an entire 
molecule by a living organism. Unlike 
biotransformation which acts on a starting substance 
or educt, biosynthesis is not dependent on educts or 
starting substances, but only on nutrients.
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Cumulative number of 
biotransformation processes 
that have been started on an 
industrial scale 
Industrial sectors in which the 
products of industrial 
biotransformations are used 
(based on 134 processes). 
Enzymes in Industry
Current Opinion in Biotechnology
 
2002, 13, 548–556
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Enzymes in Industry
Daria Giacomini
Alma Mater Studiorum
 
–
 
University of Bologna
Enzyme types used in 
industrial biotransformations 
(based on 134 processes) 
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Enzymes in Industry
The type of compounds produced using biotransformation 
processes (based on 134 industrial processes). 
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Enzymes in Industry
TRENDS IN BIOTECHNOLOGY   2008, 26, 321-327 
Enzymes in Industry
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Enzymes in Industry
Current Opinion in Biotechnology
 
2002, 13, 548–556
Selectivity
Environmentally friendly
Substrate specificity
Substrate unsolubility in aqueous 
solvents
Cofactor dependency
Expensive
Pros:
Cons:
Improvements:
Engineered enzymes
Use in organic solvents
Cofactor recycle
Immobilization
Whole cells processes
A. Straathof, Current Opinion in Biotechnology, 2002, 548
Daria Giacomini
Alma Mater Studiorum
 
–
 
University of Bologna
Zirtec
Naproxen
Chiral
 
Drugs
Xyzal
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Ibuprofen
the distomer may be inactive but....
the distomer may possess harmful side effects e.g. 
thalidomide
the distomer may be converted into the eutomer by the 
body e.g. ibuprofen.
The active enantiomer of a 
drug with the desired 
biological effect is called
the eutomer
The other enantiomer is 
called
the distomer.
Eudismic ratio is defined as the ratio of the biological activity 
of the eutomer to that of the distomer. 
Individual stereoisomers of a chiral drug should be tested as well as the racemate 
before a drug is marketed. This is because the presence of the distomer in a 
racemic drug can have important consequences on the biological activity.
Chiral
 
Drugsi l
 
J. Appl. Biomedicine
 
2004, 2: 95-100
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Synthesis of pure enantiomerst i  f  ti
Resolutions:
kinetic resolution (KR)
dynamic kinetic resolution (DKR)
Desymmetrization
Asymmetric Synthesis
Biocatalysis
 
in stereoselective
 
synthesisi t l i
 
i  t l ti
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Enzymes and kinetic resolution
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limited to 50% max yield
Enzymes and “Prils”
 
synthesis
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Enzymes and desymmetrization
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Candida parapsilosis
             ADH
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Enzymes in synthesis of antibiotics
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Daria Giacomini
Alma Mater Studiorum
 
–
 
University of Bologna
Enzymes in synthesis of antibiotics
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Enzymes in synthesis of antibiotics
Penicillin G acylase mediated synthesis of the enantiopure (S)-3-amino-azetidin-2-one
G. Cainelli. D.Giacomini,  P.Galletti,  M.DaCol
Tetrahedron: Asymmetry, Vol. 8, No. 19, pp. 3231-3235, 1997
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Enzymes in synthesis of antibiotics
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Enzymes in synthesis of anticancer drugs
Biocatalysis
 
in Atorvastatin
 
synthesis
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inhibitors of HMC-CoA
Biocatalysis
 
in Atorvastatin
 
synthesis
or
J.M. Patel J. Mol. Cat.B: Enzymatic 2009, 61, 123–128
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Dehydrogenase
 
approach
Alcohol Dehydrogenase
from Lactobacillus Brevis
Isolated Enzyme: isolated yield    75% ee > 99.5 %
Co-factor recycling:
Coupled substrate process 
with one single enzyme 
(ADH) and  isopropanol as  
co-substrate
Alcohol Dehydrogenase
from Lactobacillus Kefir
Whole cell:
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Dehydrogenase
 
approach
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Aldolase
 
approach
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Nitrilase
 
approach
Desymmetrization step
wild type
0.2 M substrate:  Y = 98% ee = 95%
3 M substrate:  Y = 89% ee = 87%
mutant 
3 M substrate  Y = 96%   ee = 98.5%
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Lipase  approach
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Lipase  approach
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Chemical versus chemo-enzymatic syntheses: 
a comparison
chemical
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Chemical versus chemo-enzymatic syntheses: 
a comparison
chemical
chemo-enzymatic
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Chemical versus chemo-enzymatic syntheses: 
a comparison
chemical
chemo-enzymatic
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Maggiore stabilità termica degli enzimi in solvente 
organico (thermal unfolding, thermal deamidation)
Aumentata solubilità dei substrati
Separazione piu’ facile dei prodotti di reazione
Multi-phase reactors
Spostamento dell’equilibrio delle  reazioni  
Selettività diversa rispetto al solvente acquoso  
“medium engineering”
Lipasi             Deidrogenasi
Enzymes in Organic solvents
Daria Giacomini
Alma Mater Studiorum
 
–
 
University of Bologna
Membrane Reactor
Biotechnology Advances 27 (2009) 286–296
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Solvent effects on enantioselectivity
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Engineered Phenylalanine Dehydrogenase
 
(PheDH-N145A)
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COOH
NH2
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X X
G.Cainelli, P.C.Engel, P.Galletti, D.Giacomini, A.Gualandi, F.Paradisi,
 
Org. Biomol. Chem., 2005, 3, 4316
Patent
 
WO 2006015885 A1 20060216 CAN 144:252784 2006.
D. Giacomini, P. Galletti, A. Quintavalla,a G. Gucciardob, F. Paradisi
 
Chem Commun, 2007, 4038
Patent Pending, PCT/EP2007/063844, RM2006A000686, University of Bologna
Dehydrogenases
 
in Organic
 
Solvents
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Engineered
 
Phenylalanine
 
Dehydrogenase
 
in Organic
 
Solvents
Engeenered Phenyl 
Alanine Dehydrogenase 
(PheDH-N145A) 
immobilised on 
Celite®521
Homogeneous system
aqueous buffer (TRIS pH 8.5) with 
miscible organic solvents
coupled enzyme 
process with 
Saccharomyces 
Cerevisiae and  ethanol  
as  co-substrate
Reaction Medium
Enzyme
Biphasic system
aqueous buffer (TRIS pH 8.5) and 
immiscible organic solvents
Co-factor recycling
PheDH-N145A on Celite
NADH NAD+
O
COOH
NH2
COOH
OHO
Saccharomyces Cerevisiae
NH4Cl
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Homogeneous medium: buffer and  THF, acetone, or methanol
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PheDH-N145A on Celite
NADH NAD+
O
COOH
NH2
COOH
OHO
Saccharomyces Cerevisiae
NH4Cl
G.Cainelli, P.C.Engel, P.Galletti, D.Giacomini, A.Gualandi, F.Paradisi,
Org. Biomol. Chem., 2005, 3, 4316
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PheDH-N145A on Celite
NADH NAD+
O
COOH
NH2
COOH
OHO
Saccharomyces Cerevisiae
NH4Cl
n-hexane
tol en t2 O
tBuOMe
C 2 Cl2
Biphasic
 
medium : buffer with
 
nhexane, toluene, Et2
 
O, tBuOMe, or CH2
 
Cl2
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Alcohol Dehydrogenases
Horse Liver Alcohol Dehydrogenases
Yeast Alcohol 
Dehydrogenases
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Horse Liver Alcohol Dehydrogenase
 
in Organic Solvents
Horse Liver Alcohol 
Dehydrogenase (HLADH)
Coupled substrate process with one 
single enzyme (HLADH) and  ethanol  
as  co-substrate
Enzyme
Co-factor recycling
Homogeneous system
aqueous buffer (phosphate pH 7.5) 
with miscible organic solvents
Reaction Medium
Biphasic system 
aqueous buffer (phosphate pH 7.5) 
and immiscible organic solvents
OHO
R
HLADH
 buffer / organic solvent
R
(R,S) (S)
OH
NADH NAD+O
H
Enantioselective
 
enzymatic
 
reduction:  2-Phenylpropanal
CHO
        HLADH 
phosphate buffer
NADH NAD+
(R,S)
OHO
OH
(S)
entry NADH recycle time (h) HLADH (mg/ml) yield % S% R%
1 no 5 0.01 81,1 82 18
2 no 24 0.01 88,5 81 19
3 yes 5 0.01 88.7 84 16
4 yes 24 0.01 99.4 83 17
5 no 5 0.002 75,1 > 99 n.d.
6 no 24 0.002 89,1 95 5
Reaction conditions. 0.5 mM 2-phenylpropanal, 1mM NADH
NADH recycle : 0.5 mM 2-phenylpropanal, 0.01 mM NADH, 0.5 M ethanol.
D. Giacomini, P. Galletti, A. Quintavalla, G. Gucciardo, F. Paradisi
 
Chem Commun, 2007, 4038
D.Giacomini, P. Galletti, F. Paradisi   Innovation Technology
 
2008, 78.
Chiralcel
 
OF, 0.5 mL/min, hexane/iPrOH
 
93/7
(R)-2-phenylpropanol 
(S)-2-phenylpropanol Chiralcel
 
OF, 0.5 
mL/min, 
hexane/iPrOH
 
93/7
Enzymatic reaction product
Racemic sample
Enantioselective
 
Bioreduction
 
with
 
Stereoinversion
CHO (S)
OH
(R)
        HLADH
phosphate buffer
NADH NAD+
OHO
OH Dess-Martin periodinane H
O
R. Berardi, G. Cainelli, P. Galletti, D. Giacomini, A. Gualandi,L. Muccioli and C. Zannoni,
J. Am. Chem. Soc., 2005, 127, 10699–10706
NADH stoich: 96% Y  (S)/(R)  96:4
NADH recycled:  95% Y  (S)/(R)  95:5
Dynamic
 
Kinetic
 
Resolution
 
process
 
via keto-enol
 
tautomerism
CHO
HLADH, NADH
 buffer- organic solvent
OH
(S)
CHO
OH
(R)
OH
slow
fast
R
R
R R
R
HLADH, NADH
 buffer- organic solvent
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(S)-substrate
(R)-substrate
(S)-product
(R)-product
fast
slow
Kinetic Resolution
max.theoretical yield 50%
(S)-substrate
(R)-substrate
(S)-product
(R)-product
fast
slow max.theoretical yield 100%
Kinetic Resolution
Dynamic
fast
Dynamic
 
Kinetic
 
Resolution: Beyond
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Dynamic
 
Kinetic
 
Resolution
 
with
 
organic
 
co-solvents
CHO
                 HLADH 
phosphate buffer / co-solvent
NADH NAD+
(R,S)
OHO
OH
(S)
entry co-solvent 
(%)
NADH 
recycle
time 
(h)
HLADH 
(mg/ml)
yield 
%
S% R%
1 CH3 CN (10) no 5 0.01 71.9 89 11
2* CH3 CN (16) yes 96 0.09 90.3 94 6
3 THF (10) no 5 0.01 54.7 96 4
4 THF (10) yes 5 0.01 54.1 95 5
5 nhexane 
(90)
no 5 0.2 69.9 74 26
6 nhexane 
(95)
no 5 0.2 80.3 64 36
7 nhexane 
(95)
yes 5 0.2 68.0 72 28
8 nhexane 
(99)
yes 5 0.2 54.6 90 10
* 1 mmol scale
Profens: a family of (S)-enantiomers
 
dedicated to inflammation 
COOH
R
COOEt
R
(R,S)
CHO
R
(R,S)EtOH
cat. H2SO4
DiBAH
ether, -78 °C
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F
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O
COOH
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Ibuprofen Naproxen Flurbiprofen
Ketoprofen Phenoprofen
Profen-aldehydes
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